Мировой рынок оборудования для управления жидкостями – тенденции отрасли и прогноз до 2029 года

 Анализ и размер рынка оборудования для управления жидкостями

Управление жидкостями является неотъемлемой частью ухода за любым госпитализированным пациентом, и его можно решать с помощью оборудования для управления жидкостями, такого как продукты для инфузионной терапии. Жидкости могут быть доставлены непосредственно в сосудистую систему с помощью альтернативных путей введения, таких как внутривенный доступ. Системы управления жидкостями выполняют различные функции, включая ирригацию жидкости, контроль дефицита, замораживание жидкости и фильтрацию жидкости, среди прочего. Ожидается, что мировой рынок систем управления жидкостями будет расти из-за растущих технологических разработок в отрасли здравоохранения, а также увеличения количества минимально инвазивных операций.

По данным Data Bridge Market Research, объем рынка оборудования для управления жидкостями, составивший в 2021 году 12,42 млрд долларов США, к 2029 году, как ожидается, достигнет 19,8 млрд долларов США при среднегодовом темпе роста 6% в прогнозируемый период с 2022 по 2029 год. Помимо информации о рыночных сценариях, таких как рыночная стоимость, темпы роста, сегментация, географический охват и основные игроки, рыночные отчеты, подготовленные Data Bridge Market Research, также включают в себя углубленный экспертный анализ, эпидемиологию пациентов, анализ конвейера, анализ цен и нормативную базу.

Объем и сегментация рынка оборудования для управления жидкостями

Market Definition

Fluid management equipment is an essential component of any hospitalised patient's care, which can be addressed with fluid management equipment such as infusion therapy products. Fluids can be delivered directly to the vascular system via alternative routes of administration such as intravenous access. Fluid management is an important part of junior doctor prescribing, whether working on a surgical firm with a nil-by-mouth patient or on a care of the elderly firm with a dehydrated patient.

Global Fluid Management Equipment Market Dynamics

Drivers

• Growing prevalence of cardiovascular diseases to drive the demand

The growing prevalence of cardiovascular diseases around the world is the primary driver of the market. For instance, according to a report published by the Centers for Disease Control and Prevention (CDC) in 2021, more than 795,000 people in the United States suffer from stroke each year. One in every 610,000 people suffers from a stroke for the first time. Ischemic strokes account for approximately 87.0% of all strokes. Similarly, according to a report published by the Government of the United Kingdom in 2021, approximately 210,800 men were offered screening for aortic aneurysms, with approximately 1,542 aneurysms detected among them and approximately 848 men with large aneurysms referred for surgery. This factor propel the growth of the market.

• Rise in number of dialysis centers across the world will push the growth

Globally, the number of dialysis centres is growing. During the forecast period, this is expected to drive the fluid management equipment market. According to the Centers for Medicare and Medicaid Services, there were 5,698 dialysis centres in the United States in 2010, up from 4,789 in 2005. Furthermore, emerging-market governments are establishing new dialysis centres and improving existing dialysis centres.

Opportunities

• Government initiatives have been a strong driving force

Leading players in the global fluid management equipment market in cpollaboration with the government have taken initiatives to reach as many ESRD patients as possible across all regions by expanding dialysis centres. B. Braun Melsungen AG alone operates over 300 facilities in Europe, Africa, and Asia Pacific. On World Kidney Day, March 9, 2017, Fresenius Medical Care launched a brand new Asia Pacific-wide corporate social responsibility initiative, reaching 6600 children, parents, and caregivers, as well as media, key renal health partners, and government officials.

Restraints/Challenges

• Stringent regulatory approval procedures will create obstructions

Stringent regulatory requirements and the lengthy FDA approval process have discouraged medical device OEMs in the United States such as Asia and Latin America, to launch newer products in the market. The high investment in R&D and clinical trials is currently the most significant barrier for orthopaedic device manufacturers. Slow approval processes increase costs and provide a low return on investment for stakeholders. Increasing competition among players and increasing preferences over simple machines and consolidate equipment and need for cost control to gain competitive lead will obstruct the market's growth rate.

This fluid management equipment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the fluid management equipment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent developments

• In April 2022, Transit Scientific announced the FDA clearance of its XO Cross Support catheter platform for coronary use. The platform is intended to guide and support the guidewire during access to the peripheral or coronary vasculature, to allow wire exchange, and to provide guidance for saline or diagnostic contrast agent administration.
• In February 2022, Medtronic plc announced that the Freezor and Freezor Xtra Cardiac Cryoablation Focal Catheters were the first and only ablation catheters approved by the FDA to treat the growing prevalence of paediatric Atrioventricular Nodal Reentrant Tachycardia (AVNRT).

Global Fluid Management Equipment Market Scope

The fluid management equipment market is segmented on the basis of product, application, end-use. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Infusion Therapy Products
• Endoscopic Fluid Management Products
• Renal Fluid Management Products

 Application

• Cardiology
• Urology
• Neurology
• Orthopaedic/Osteology
• Gastroenterology
• Oncology
• Others

End-Use

• Hospitals
• Clinics
• Diagnostics Centres
• Home Care Setting
• Others

Fluid Management Equipment Market Regional Analysis/Insights

The fluid management equipment market is analysed and market size insights and trends are provided by country, product, application, end-use as referenced above.

The countries covered in the fluid management equipment market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the fluid management equipment market due to the largest market share, with high incidence rate of the diseases, advancements in healthcare sector supporting in the growth of the market in the region and technologies advancements in healthcare sector.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 owing to changing lifestyles of the populations leading to high incidence of lifestyle diseases and growing number of surgical procedures performed in these regions.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

Рынок оборудования для управления жидкостями также предоставляет вам подробный анализ рынка для каждой страны по росту расходов на здравоохранение для капитального оборудования, установленной базы различных видов продукции для рынка оборудования для управления жидкостями, влияния технологии с использованием кривых линии жизни и изменений в сценариях регулирования здравоохранения и их влияния на рынок оборудования для управления жидкостями. Данные доступны за исторический период 2010-2020 гг.

Анализ конкурентной среды и доли рынка оборудования для управления жидкостями

Конкурентная среда рынка оборудования для управления жидкостями содержит сведения по конкурентам. Включены сведения о компании, финансы компании, полученный доход, рыночный потенциал, инвестиции в исследования и разработки, новые рыночные инициативы, глобальное присутствие, производственные площадки и объекты, производственные мощности, сильные и слабые стороны компании, запуск продукта, широта и широта продукта, доминирование в применении. Приведенные выше данные относятся только к фокусу компаний, связанному с рынком оборудования для управления жидкостями.

Некоторые из основных игроков, работающих на рынке оборудования для управления жидкостями:

• Страйкер (США)
• ICU Medical, Inc. (США)
• Корпорация Olympus (Япония)
• Fresenius Medical Care AG & Co. kGaA (Германия)
• КОНМЕД (США)
• B.Braun SE (Германия)
• Бакстер (США)
• Ecolab (США)
• F. Hoffmann-La Roche Ltd (Швейцария)
• Medtronic (Ирландия)
• БД (США)
• ALCOR Scientific (США)
• АнгиоДинамика (США)
• Cardinal Health (США)
• Smiths Group plc (Великобритания)
• Zimmer Biomet (США)
• КАРЛ ШТОРЦ (Германия)
• Richard Wolf GmbH (Германия)
• Pfizer Inc. (США)

SKU-55900